Product Search

E-Newsletter

Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

02 November 2017

Funding to develop liver targeted gene activation therapies

London and Bellshill, United Kingdom, November 2, 2017 - MiNA Therapeutics, the pioneer in RNA activation therapeutics, and LGC LINK, the oligonucleotide synthesis reagent manufacturer, and part of the Genomics division of LGC, today announced that Innovate UK has awarded the two companies a grant to develop liver targeted gene activation therapies for the treatment of liver diseases. The grant of up to approximately £400,000, with additional funding from MiNA and LGC LINK, will support a two-year research project.

Read full press release.

Tags: Press Releases , Deals

  • Comments (0)   Commenting is now closed.
  • Posted by David

Back to latest blog posts